Oncodesign Precision Medicine 

€0.45
3
+€0.01+2.97% Thursday 07:55

Statistics

Day High
0.43
Day Low
0.43
52W High
0.78
52W Low
0.27
Volume
-
Avg. Volume
-
Mkt Cap
8.2M
P/E Ratio
1.25
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q4 2023
Q2 2024
Q1 2025
Q2 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,288.21%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
789,000Revenue
-18.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZR8.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company's product pipeline consist of OPM-101, a RIPK2 inhibitor for the treatment of inflammatory bowel disease and immuno-oncology; OPM-102 to treat cancer; and OPM-201, a LRRK2 inhibitor for the treatment of Parkinson's disease. It also focuses on the development of a radiotheranostic molecule portfolio for the diagnosis and the treatment of advanced digestive cancers, as well as on developing treatment for pancreatic and other cancers. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France.
Show more...
CEO
Dr. Philippe Genne Ph.D.
Employees
14
Country
FR
ISIN
FR001400CM63
WKN
000A3DVNM

Listings

0 Comments

Share your thoughts

FAQ

What is Oncodesign Precision Medicine stock price today?
The current price of ZR8.F is €0.45 EUR — it has increased by +2.97% in the past 24 hours. Watch Oncodesign Precision Medicine stock price performance more closely on the chart.
What is Oncodesign Precision Medicine stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Oncodesign Precision Medicine stocks are traded under the ticker ZR8.F.
Is Oncodesign Precision Medicine stock price growing?
ZR8.F stock has fallen by -1.96% compared to the previous week, the month change is a -20.88% fall, over the last year Oncodesign Precision Medicine has showed a +28.13% increase.
What is Oncodesign Precision Medicine market cap?
Today Oncodesign Precision Medicine has the market capitalization of 8.2M
What is Oncodesign Precision Medicine revenue for the last year?
Oncodesign Precision Medicine revenue for the last year amounts to 789,000 EUR.
What is Oncodesign Precision Medicine net income for the last year?
ZR8.F net income for the last year is -18.05M EUR.
How many employees does Oncodesign Precision Medicine have?
As of April 05, 2026, the company has 14 employees.
In which sector is Oncodesign Precision Medicine located?
Oncodesign Precision Medicine operates in the Health Care sector.
When did Oncodesign Precision Medicine complete a stock split?
Oncodesign Precision Medicine has not had any recent stock splits.
Where is Oncodesign Precision Medicine headquartered?
Oncodesign Precision Medicine is headquartered in Dijon, FR.